Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Docetaxel market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Docetaxel market segmented into
40 mg/ml
20 mg/ml
10 mg/ml
Based on the end-use, the global Docetaxel market classified into
Breast cancer
Non-small cell lung cancer
Prostate cancer
Gastric adenocarcinoma cancer
Head and neck cancer
Based on geography, the global Docetaxel market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Sanofi-Aventis
Pfizer
Teva
Taj Pharmaceuticals
Dr. Reddy
Sandoz
Actavis
Sun pharma
Beijing Union Pharmaceutical
Cisen Pharmaceutical
Qilu Pharma
Taiji Group
Jiangsu Hengrui
Accord Healthcare
Eagle Pharmaceuticals
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DOCETAXEL INDUSTRY
2.1 Summary about Docetaxel Industry
2.2 Docetaxel Market Trends
2.2.1 Docetaxel Production & Consumption Trends
2.2.2 Docetaxel Demand Structure Trends
2.3 Docetaxel Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 40 mg/ml
4.2.2 20 mg/ml
4.2.3 10 mg/ml
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Breast cancer
4.3.2 Non-small cell lung cancer
4.3.3 Prostate cancer
4.3.4 Gastric adenocarcinoma cancer
4.3.5 Head and neck cancer
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 40 mg/ml
5.2.2 20 mg/ml
5.2.3 10 mg/ml
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Breast cancer
5.3.2 Non-small cell lung cancer
5.3.3 Prostate cancer
5.3.4 Gastric adenocarcinoma cancer
5.3.5 Head and neck cancer
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 40 mg/ml
6.2.2 20 mg/ml
6.2.3 10 mg/ml
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Breast cancer
6.3.2 Non-small cell lung cancer
6.3.3 Prostate cancer
6.3.4 Gastric adenocarcinoma cancer
6.3.5 Head and neck cancer
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 40 mg/ml
7.2.2 20 mg/ml
7.2.3 10 mg/ml
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Breast cancer
7.3.2 Non-small cell lung cancer
7.3.3 Prostate cancer
7.3.4 Gastric adenocarcinoma cancer
7.3.5 Head and neck cancer
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 40 mg/ml
8.2.2 20 mg/ml
8.2.3 10 mg/ml
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Breast cancer
8.3.2 Non-small cell lung cancer
8.3.3 Prostate cancer
8.3.4 Gastric adenocarcinoma cancer
8.3.5 Head and neck cancer
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 40 mg/ml
9.2.2 20 mg/ml
9.2.3 10 mg/ml
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Breast cancer
9.3.2 Non-small cell lung cancer
9.3.3 Prostate cancer
9.3.4 Gastric adenocarcinoma cancer
9.3.5 Head and neck cancer
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi-Aventis
10.1.2 Pfizer
10.1.3 Teva
10.1.4 Taj Pharmaceuticals
10.1.5 Dr. Reddy
10.1.6 Sandoz
10.1.7 Actavis
10.1.8 Sun pharma
10.1.9 Beijing Union Pharmaceutical
10.1.10 Cisen Pharmaceutical
10.1.11 Qilu Pharma
10.1.12 Taiji Group
10.1.13 Jiangsu Hengrui
10.1.14 Accord Healthcare
10.1.15 Eagle Pharmaceuticals
10.2 Docetaxel Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi-Aventis
10.2.2 Pfizer
10.2.3 Teva
10.2.4 Taj Pharmaceuticals
10.2.5 Dr. Reddy
10.2.6 Sandoz
10.2.7 Actavis
10.2.8 Sun pharma
10.2.9 Beijing Union Pharmaceutical
10.2.10 Cisen Pharmaceutical
10.2.11 Qilu Pharma
10.2.12 Taiji Group
10.2.13 Jiangsu Hengrui
10.2.14 Accord Healthcare
10.2.15 Eagle Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
Table Docetaxel Product Type Overview
Table Docetaxel Product Type Market Share List
Table Docetaxel Product Type of Major Players
Table Brief Introduction of Sanofi-Aventis
Table Brief Introduction of Pfizer
Table Brief Introduction of Teva
Table Brief Introduction of Taj Pharmaceuticals
Table Brief Introduction of Dr. Reddy
Table Brief Introduction of Sandoz
Table Brief Introduction of Actavis
Table Brief Introduction of Sun pharma
Table Brief Introduction of Beijing Union Pharmaceutical
Table Brief Introduction of Cisen Pharmaceutical
Table Brief Introduction of Qilu Pharma
Table Brief Introduction of Taiji Group
Table Brief Introduction of Jiangsu Hengrui
Table Brief Introduction of Accord Healthcare
Table Brief Introduction of Eagle Pharmaceuticals
Table Products & Services of Sanofi-Aventis
Table Products & Services of Pfizer
Table Products & Services of Teva
Table Products & Services of Taj Pharmaceuticals
Table Products & Services of Dr. Reddy
Table Products & Services of Sandoz
Table Products & Services of Actavis
Table Products & Services of Sun pharma
Table Products & Services of Beijing Union Pharmaceutical
Table Products & Services of Cisen Pharmaceutical
Table Products & Services of Qilu Pharma
Table Products & Services of Taiji Group
Table Products & Services of Jiangsu Hengrui
Table Products & Services of Accord Healthcare
Table Products & Services of Eagle Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Docetaxel Market Forecast (Million USD) by Region 2021f-2026f
Table Global Docetaxel Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Docetaxel Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Docetaxel Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Docetaxel Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Docetaxel Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Docetaxel Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Docetaxel Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Docetaxel Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Docetaxel Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Docetaxel Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 40 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 20 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 10 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-small cell lung cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gastric adenocarcinoma cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Head and neck cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 40 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 20 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 10 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-small cell lung cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gastric adenocarcinoma cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Head and neck cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 40 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 20 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 10 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-small cell lung cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gastric adenocarcinoma cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Head and neck cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 40 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 20 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 10 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-small cell lung cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gastric adenocarcinoma cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Head and neck cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 40 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 20 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 10 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-small cell lung cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gastric adenocarcinoma cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Head and neck cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 40 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 20 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure 10 mg/ml Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Breast cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Non-small cell lung cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prostate cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gastric adenocarcinoma cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Head and neck cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Docetaxel Sales Revenue (Million USD) of Sanofi-Aventis 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Teva 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Taj Pharmaceuticals 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Dr. Reddy 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Sandoz 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Actavis 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Sun pharma 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Beijing Union Pharmaceutical 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Cisen Pharmaceutical 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Qilu Pharma 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Taiji Group 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Jiangsu Hengrui 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Accord Healthcare 2017-2020e
Figure Docetaxel Sales Revenue (Million USD) of Eagle Pharmaceuticals 2017-2020e
